Accuracy of the Optical Diagnosis of Small Colonic Polyps Using the Nice Classification
NCT ID: NCT02009774
Last Updated: 2015-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
380 participants
OBSERVATIONAL
2014-01-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study we want to proof that the use of a new narrow-band imaging (NBI) tool (Exera III, Olmpus) is capable to rise accuracy of optically ascertained diagnoses of colonic polyps. NBI is a light filter tool which can be activated by pressing a button at the endoscope. NBI function leads to an endoscopic picture which appears blue and enables endoscopists to better assess surface structures and vascular patterns.
In a prospective randomised multicenter setting we plan to conduct colonoscopy in 380 patients. Half of the patients will be examined without use of NBI (control arm). In these cases colonoscopists will assess optical diagnosis of polyps without turning on the NBI tool. If polyps are detected in patients belonging to the intervention arm NBI will be used and optical diagnosis will be determined using the NICE (NBI International Colorectal Endoscopic) classification. All polyps will be resected and send to pathology for further microscopic assessment. After completing the trial we aim to compare accuracy of the optical diagnosis in both groups. Our hypothesis is, that by using the new NBI tool accuracy (accordance between optical and histopathological diagnosis) can be increased from 78% to 90%.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer Assisted Optical Assessment of Small Colorectal Polyps
NCT02522702
Computer Assisted Measurement of Colorectal Polyps
NCT02970760
Acetic Acid for Optical Characterization of Colonic Polyps
NCT02760381
Optical Polyp Testing for In Vivo Classification
NCT03139942
NBI Versus White Light Endoscopy for Optical Characterization of Neoplastic Polyps in the Colorectum
NCT03679429
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controll group
Patients from the control group will be examined using a CF-HQ 190 EVIS Exera III Advanced Diagnostic Video Colonoscope. If colon polyps are detected optical diagnosis will be determined WITHOUT using the NBI function of the scope.
No interventions assigned to this group
Intervention
Patients from the control group will be examined using a CF-HQ 190 EVIS Exera III Advanced Diagnostic Video Colonoscope. If colon polyps are detected optical diagnosis will be determined WITH THE HELP OF the NBI function of the scope.
NBI Function
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NBI Function
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>18 years
* written consent given by patient
Exclusion Criteria
* patients denying written consent
* pregnant women
* ASA class IV, V and VI
* known contraindication for polyp resection
* indication for colonoscopy: preknown adenoma/polyp/carcinoma
* indication for colonoscopy: emergency (e.g. severe rectal bleeding)
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Olympus
INDUSTRY
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Peter Klare
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Klare, MD
Role: PRINCIPAL_INVESTIGATOR
Klinikum rechts der Isar der Technischen Universität München
Stefan von Delius, MD
Role: STUDY_DIRECTOR
Klinikum rechts der Isar der Technischen Universität München
Jörg Albert, MD
Role: STUDY_CHAIR
Medizinische Klinik I University Hospital Frankfurt
Ellen C Nötzel, MD
Role: STUDY_CHAIR
Innere Medizin I, Sana Klinikum Lichtenberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München
Munich, Bavaria, Germany
Medizinische Klinik I des Universitätsklinikums Frankfurt
Frankfurt am Main, Hesse, Germany
Innere Medizin I am Sana Klinikum Lichtenberg
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Klare P, Haller B, Wormbt S, Notzel E, Hartmann D, Albert J, Hausmann J, Einwachter H, Weber A, Abdelhafez M, Schmid RM, von Delius S. Narrow-band imaging vs. high definition white light for optical diagnosis of small colorectal polyps: a randomized multicenter trial. Endoscopy. 2016 Oct;48(10):909-15. doi: 10.1055/s-0042-110650. Epub 2016 Jul 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ADOPTION
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.